Baxter UK

Baxter UK
Labelling for Safety

A National Patient Safety Agency (NPSA) Directive was issued highlighting the issue of "for safety" as many injectable and infused products had similar names and similar labelling. A situation that can lead to medication errors.

Quadrant worked closely with Baxter to rationalise the current labelling system and develop a new system that would help users to more simply identify compounded products. The new labelling had to meet the needs of pharmacists but also work within the existing Baxter protocols and operating procedures. After producing a range of concepts the designs were tested with key opinion leaders and ultimately core templates developed for a range of new labelling.

More from Baxter
IV Catalogue on a DVD
The Ultimate 40th Party
Rebranding Infusors

a selection of our work

Baxter EMEA
IV Catalogue on a DVD
Print | Marketing

Johnson & Johnson
Awards programme
Print | Web | Marketing | Event

Research International Group
A Truly Global Conference
Print | Event

Creating an online resource to share creative material